Generation of human erythroblast-derived iPSC line using episomal reprogramming system

Area of Science:

• Stem Cell Biology
• Cellular Reprogramming
• Regenerative Medicine

Background:

• Peripheral blood mononuclear cells (PBMCs) are an accessible source for cell-based therapies.
• Efficient generation of homogenous cell populations is crucial for clinical applications.
• Transgene-free induced pluripotent stem cells (iPSCs) offer safety advantages over traditional methods.

Purpose of the Study:

• To establish a transgene-free induced pluripotent stem cell (iPSC) line from peripheral blood.
• To develop an efficient and cost-effective reprogramming system.
• To verify the pluripotency and genetic stability of the generated iPSC line.

Main Methods:

• Isolation and culture of peripheral blood mononuclear cells to obtain pro-EBLs.
• Reprogramming of pro-EBLs into iPSCs using episomal plasmids.
• Verification of pluripotency through marker expression and in vitro differentiation assays.
• Karyotyping to assess genetic stability.

Main Results:

• A pure pro-EBL population was successfully cultured from peripheral blood.
• Transgene-free iPSCs were generated efficiently using episomal reprogramming.
• The generated iPSC line expressed pluripotency markers and differentiated into three germ layers.
• The iPSC line maintained a normal karyotype.

Conclusions:

• Peripheral blood is a viable and accessible source for generating iPSCs.
• Episomal delivery provides a transgene-free, cost-effective reprogramming system.
• This method enables routine generation of homogenous iPSC lines within a week for potential therapeutic use.